Virtus LifeSci Profile

Performance

   

Odds of Distress

Check how we calculate scores
Equity ratings for Virtus LifeSci Biotech Clinical are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting July 15, 2019 and ending today October 13, 2019. Click here to learn more.

Virtus LifeSci Profile

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Virtus LifeSci is traded on BATS Exchange in USA. more
NameVirtus LifeSci Biotech Clinical
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerVirtus
ExchangeBATS Exchange
Etf FamilyVirtus
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone888 383 0553
CurrencyUSD - US Dollar
IssuerVirtus
DescriptionVirtus LifeSci Biotech Clinical Trials ETF
Inception Date2014-12-16
BenchmarkLifeSci Biotechnology Clinical Trials Index
Entity TypeRegulated Investment Company
Asset Under Management21.16 Million
Average Trading Valume5,593.5
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorVirtus ETF Solutions LLC
AdvisorVirtus ETF Advisers LLC
CustodianThe Bank of New York Mellon Corporation
DistributorETF Distributors LLC
Portfolio ManagerMatthew B. Brown, Seth Kadushin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year End31-Oct
ExchangeNYSE Arca
Number of Constituents98.0
Market MakerVirtu Financial
Total Expense0.79
Management Fee0.79
Nav Price23.2
Two Hundred Day Average27.4
Ytd2.54%
Average Daily Volume In Three Month4.1k
Fifty Two Week Low20.22
As Of DateSeptember 30, 2019
Average Daily Volume Last 10 Day2.71k
Fifty Two Week High30.86
One Month-10.12%
Fifty Day Average26.02
Three Month-17.30%
Virtus LifeSci Biotech Clinical [BBC] is traded in USA and was established 2014-12-16. The fund is classified under Health category within Virtus family. Virtus LifeSci Biotech currently have 21.48 M in assets under management (AUM). , while the total return for the last 3 years was 2.06%.
Check Virtus LifeSci Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

Top Etf Constituents

Virtus LifeSci Target Price Odds Analysis

Odds Below 24.0HorizonTargetOdds Above 24.0
4.89%30 days 24.00 95.05%
Based on normal probability distribution, the odds of Virtus LifeSci to move above current price in 30 days from now is over 95.05 (This Virtus LifeSci Biotech Clinical probability density function shows the probability of Virtus LifeSci Etf to fall within a particular range of prices over 30 days) .

Virtus LifeSci Biotech Top Holders

Virtus LifeSci Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Royal Bank Of CanadaFund Units116.7 K3.4 M
View Virtus LifeSci Diagnostics

Virtus LifeSci Biotech Risk Profiles

Virtus LifeSci Biotech Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Virtus LifeSci Price Natural Logarithm is logarithm with base 'e' where e is equal to 2.718281828. It is applied on the entire Virtus LifeSci Biotech pricing series. View also all equity analysis or get more info about price natural logarithm math transform indicator.

Virtus LifeSci Key Fundamentals

Virtus LifeSci Against Markets

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module
Check also Trending Equities. Please also try Theme Ratings module to determine theme ratings based on digital equity recommendations. macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Search macroaxis.com